Displaying drugs 851 - 875 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Fenofibric acid | 318.75 C17H15ClO4 |  | A fibrate used to treat severe hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. | Fibric Acids |
| Tedizolid | 370.344 C17H15FN6O3 |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Balsalazide | 357.3175 C17H15N3O6 |  | An aminosalicylate used to treat ulcerative colitis. | Salicylates |
| Zaleplon | 305.3339 C17H15N5O |  | A sedative used for short term treatment of insomnia in adults. | Anticonvulsants / GABA Modulators / gamma-Aminobutyric Acid A Receptor Agonist |
| Benorilate | 313.309 C17H15NO5 |  | Not Annotated | Salicylic Acid and Derivatives |
| Amoxapine | 313.781 C17H16ClN3O |  | A tricyclic antidepressant used in the treatment of neurotic or reactive depressive disorders and endogenous or psychotic depression. | Non-Selective Monoamine Reuptake Inhibitors |
| Asenapine | 285.77 C17H16ClNO |  | An atypical antipsychotic used to treat patients with bipolar I disorder and patients with schizophrenia. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Mefloquine | 378.3122 C17H16F6N2O |  | An antimalarial agent used in the prophylaxis and treatment of malaria caused by Plasmodium falciparum and Plasmodium vivax. | Antimalarial methanolquinolines |
| Vonoprazan | 345.39 C17H16FN3O2S |  | A potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication. | Alimentary Tract and Metabolism / Amides / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs for Acid Related Disorders / Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) / Gastric Acid Lowering Agents / P-glycoprotein inhibitors / Potassium-competitive Acid Blockers / Sulfones / Sulfur Compounds |
| Tedizolid phosphate | 450.323 C17H16FN6O6P |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Eslicarbazepine acetate | 296.326 C17H16N2O3 |  | An anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy. | Carboxamide Derivatives |
| Sertraline | 306.23 C17H17Cl2N |  | A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions. | Antidepressive Agents Indicated for Depression / Drugs causing inadvertant photosensitivity / Selective Serotonin Reuptake Inhibitors / Serotonin Modulators |
| Eszopiclone | 388.808 C17H17ClN6O3 |  | A sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep. | Drugs causing inadvertant photosensitivity / Piperazines / Pyrazines / Pyridines |
| Zopiclone | 388.808 C17H17ClN6O3 |  | A nonbenzodiazepine hypnotic used for the short-term management of insomnia. | Drugs causing inadvertant photosensitivity / Sleep Initiation and Maintenance Disorders |
| Griseofulvin | 352.766 C17H17ClO6 |  | An antifungal agent used to treat a variety of superficial tinea infections and fungal infections of the fingernails and toes. | Antifungals for Systemic Use |
| Cefapirin | 423.463 C17H17N3O6S2 |  | A first generation cephalosporin indicated in the treatment of susceptible bacterial infections. | Anti-Bacterial Agents / First-Generation Cephalosporins |
| Cefotetan | 575.619 C17H17N7O8S4 |  | An antibiotic medication used for the prophylaxis and treatment of various bacterial infections, including urinary tract infections, bone and joint infection, and lower respiratory tract infections. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Apomorphine | 267.3224 C17H17NO2 |  | A morphine derivative D2 dopamine agonist used to treat hypomobile "off" episodes of advanced Parkinson's disease. | Drugs Used in Erectile Dysfunction |
| Fluoxetine | 309.3261 C17H18F3NO |  | A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia, OCD, premenstrual dysphoric disorder, panic disorder, and bipolar I. | Antidepressive Agents Indicated for Depression / Antidepressive Agents, Second-Generation / Cytochrome P-450 CYP2D6 Inhibitors / Propylamines / Selective Serotonin Reuptake Inhibitors / Serotonin Modulators |
| Ciprofloxacin | 331.3415 C17H18FN3O3 |  | A second generation fluoroquinolone used to treat various susceptible bacterial infections. | Fluoroquinolones |
| Piretanide | 362.4 C17H18N2O5S |  | A loop diuretic used to manage essential arterial hypertension and edema cardiac, hepatic, and renal origin. | Sulfonamides |
| Nifedipine | 346.3346 C17H18N2O6 |  | A dihydropyridine calcium channel blocker indicated for the management of several subtypes of angina pectoris, and hypertension. | Beta blocking agents and calcium channel blockers / Dihydropyridine Derivatives |
| Carbenicillin | 378.4 C17H18N2O6S |  | For the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria due to susceptible strains of bacteria. | Penicillins With Extended Spectrum |
| Alosetron | 294.351 C17H18N4O |  | A 5-HT3 antagonist used to treat diarrhea-predominant IBS. | Gastrointestinal Agents / Serotonin 5-HT3 Receptor Antagonists / Serotonin Receptor Antagonists |
| Ruxolitinib | 306.365 C17H18N6 |  | A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment. | Agents for Dermatitis, Excluding Corticosteroids / Protein Kinase Inhibitors |
Displaying drugs 851 - 875 of 2785 in total